ALLMedicine™ Prostatic Hyperplasia Center
Research & Reviews 3,491 results
https://doi.org/10.1007/s00345-021-03688-4 10.5489/cuaj.5616 10.1136/bmjopen-2018-028855 10.1097/JU.0000000000000319 10.1016/j.eururo.2015.07.054 10.1016/j.eururo.2013.10.040 10.1089/end.2019.0478 10.1016/j.juro.2015.03.113 10.1111/bju.13822 10.1016/j.urology.2016.01.021 10.1186/s13063-018-3066-9 10.1016/j.juro.2012.02.2576 10.1016/j.eururo.2013.02.026 10.1016/j.eururo.2010.05.026 10.23736/S0393-2249.20.03597-3
World Journal of Urology; Law KW, Tholomier C et. al.
Apr 10th, 2021 - Greenlight photo-selective vaporization of the prostate (GL-PVP) has gained international acceptance as a safe and effective alternative procedure for the treatment of benign prostatic hyperplasia (BPH), especially in anticoagulated men. This desc...
https://doi.org/10.1038/s41391-021-00362-z 10.1046/j.1464-410x.1999.00908.x 10.1097/JU.0000000000000319 10.1016/0090-4295(93)90335-8 10.1002/pros.2990170505 10.2147/VHRM.S81122 10.1016/S0022-5347(01)66780-6 10.1016/j.juro.2013.05.116 10.1016/j.juro.2015.10.181 10.1371/journal.pone.0174586 10.1007/s11136-005-3232-x
Prostate Cancer and Prostatic Diseases; Kaplan SA, Pichardo M et. al.
Apr 9th, 2021 - This is the first report of the 1-year outcomes of the EVEREST-I study evaluating the safety and efficacy of the Optilume® BPH Catheter System, a prostatic paclitaxel-coated balloon catheter system, for the treatment of lower urinary tract symptom...
https://doi.org/10.1038/s41443-021-00421-y 10.1007/s11255-015-1206-7 10.1016/j.eururo.2013.03.004 10.1016/j.juro.2011.01.074 10.1210/jc.2003-030330 10.3109/13685538.2016.1145205 10.1111/andr.12353 10.1111/jdv.14223 10.2340/00015555-3084 10.5534/wjmh.180082 10.1111/j.1743-6109.2012.02759.x 10.1016/j.euf.2019.05.014 10.1097/MD.0000000000017848 10.1111/j.1464-410X.2008.07498.x 10.1016/j.jep.2020.112779 10.1038/srep31906 10.1038/s41598-019-56145-z 10.1089/acm.2016.0302 10.1016/j.jep.2016.05.052 10.1080/01635581.2014.904911 10.1158/1940-6207.CAPR-14-0172 10.3390/ijms12063757 10.1016/j.fct.2012.08.004 10.1002/ptr.3001 10.1021/jf011102r 10.1021/jf800038h 10.1155/2014/640746 10.1677/joe.0.1810493 10.1038/sj.ijir.3901153 10.1177/1535370213508360 10.1016/j.phymed.2004.12.001 10.1016/S0022-5347(17)37500-6 10.1016/1043-6618(94)80012-X 10.1111/j.1743-6109.2011.02425.x 10.1111/j.1743-6109.2010.01992.x 10.1002/nau.24333 10.1161/ATVBAHA.110.209783 10.1073/pnas.1202916109 10.1007/BF01854965 10.3923/pjbs.2008.1569.1575 10.1016/j.ejphar.2016.08.006 10.1016/j.pain.2008.12.021 10.1016/j.jprot.2010.02.014 10.1016/j.eururo.2007.10.024 10.1016/j.niox.2015.08.005 10.1097/00005344-199904000-00001 10.1186/1743-7075-11-57 10.1097/01.hjh.0000198029.22472.d9 10.1016/j.biopha.2018.08.128 10.1186/s12933-016-0366-9 10.1111/jsm.12786 10.1021/jf0712503 10.1248/bpb.b17-00116 10.1016/S0302-2838(03)00198-2 10.1038/sj.bjc.6600825
International Journal of Impotence Research; Yilmaz-Oral D, Onder A et. al.
Apr 6th, 2021 - Benign prostatic hyperplasia (BPH) is one of the most prevalent conditions among aged men. The use of 5α-reductase inhibitors (5-ARIs) to treat BPH was linked to erectile dysfunction (ED). Many medicinal plants and secondary metabolites are used i...
https://doi.org/10.1080/13685538.2021.1901273
The Aging Male : the Official Journal of the Internationa... Wong A, Mahmalji W
Apr 5th, 2021 - Acute urinary retention (AUR) is one of the most significant complication of benign prostatic hyperplasia (BPH). The gold standard surgical treatment for BPH, transurethral resection of the prostate (TURP), is not without significant side effects ...
https://doi.org/10.1007/s00345-021-03685-7 10.1016/S0140-6736(03)13073-5 10.1016/j.juro.2008.03.141 10.1007/s00345-020-03219-7 10.1016/S0302-2838(03)00376-2 10.1016/j.eururo.2014.12.038 10.23736/S0393-2249.19.03589-6 10.1016/j.eururo.2017.07.005 10.1007/s00345-019-02852-1 10.1111/j.1464-410X.2010.09954.x 10.1016/j.urology.2006.08.1115 10.1038/sj.pcan.4500654 10.1016/j.eururo.2013.01.008 10.1111/bju.12982 10.1016/j.juro.2017.01.056 10.1016/j.juro.2015.10.181 10.1111/bju.14249 10.1038/nrurol.2015.169 10.1016/j.prnil.2017.01.007 10.1007/s00270-017-1662-9 10.1038/s41391-019-0196-4 10.1111/bju.14608 10.1111/bju.13358 10.1016/j.urology.2017.10.023 10.1016/j.eururo.2019.11.010 10.1111/bju.14917 10.1111/bju.14990 10.1016/j.juro.2013.12.004 10.1007/s00345-018-2509-y
World Journal of Urology; Frego N, Saita A et. al.
Apr 3rd, 2021 - To evaluate the feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation (TPLA) as a new minimally invasive surgical therapy (MIST) for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic h...
Guidelines 7 results
https://doi.org/10.1097/JU.0000000000001298
The Journal of Urology; Parsons JK, Dahm P et. al.
Jul 23rd, 2020 - The AUA Guideline panel provides evidence-based recommendations for the surgical management of male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The Panel amended the Guideline in 2020 to reflect additional ...
https://doi.org/10.1097/JU.0000000000000319
The Journal of Urology; Foster HE, Dahm P et. al.
May 6th, 2019 - Male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is common in men and can have negative effects on quality of life (QoL). It is the hope that this Guideline becomes a reference for effective evidence-based s...
https://doi.org/10.1016/j.juro.2018.05.048
The Journal of Urology; Foster HE, Barry MJ et. al.
May 18th, 2018 - Male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is common in men and can have negative effects on quality of life (QoL). It is the hope that this Guideline becomes a reference on the effective evidence-base...
http://www.auanet.org/guidelines/benign-prostatic-hyperplasia/lower-urinary-tract-symptoms-(2018)
Harris E. Foster
Apr 30th, 2018 - Benign prostatic hyperplasia (BPH) is a histologic diagnosis that refers to the proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The prevalence and the severity of lower urinary tract symptoms (LUTS) in the.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778754
Investigative and Clinical Urology; Yeo JK, Choi H et. al.
Mar 11th, 2016 - In 2014, the Korean Urological Association organized the Benign Prostatic Hyperplasia Guideline Developing Committee composed of experts in the field of benign prostatic hyperplasia (BPH) with the participation of the Korean Academy of Family Medi...
Drugs 803 results see all →
Clinicaltrials.gov 4,389 results
https://doi.org/10.1007/s00345-021-03688-4 10.5489/cuaj.5616 10.1136/bmjopen-2018-028855 10.1097/JU.0000000000000319 10.1016/j.eururo.2015.07.054 10.1016/j.eururo.2013.10.040 10.1089/end.2019.0478 10.1016/j.juro.2015.03.113 10.1111/bju.13822 10.1016/j.urology.2016.01.021 10.1186/s13063-018-3066-9 10.1016/j.juro.2012.02.2576 10.1016/j.eururo.2013.02.026 10.1016/j.eururo.2010.05.026 10.23736/S0393-2249.20.03597-3
World Journal of Urology; Law KW, Tholomier C et. al.
Apr 10th, 2021 - Greenlight photo-selective vaporization of the prostate (GL-PVP) has gained international acceptance as a safe and effective alternative procedure for the treatment of benign prostatic hyperplasia (BPH), especially in anticoagulated men. This desc...
https://doi.org/10.1038/s41391-021-00362-z 10.1046/j.1464-410x.1999.00908.x 10.1097/JU.0000000000000319 10.1016/0090-4295(93)90335-8 10.1002/pros.2990170505 10.2147/VHRM.S81122 10.1016/S0022-5347(01)66780-6 10.1016/j.juro.2013.05.116 10.1016/j.juro.2015.10.181 10.1371/journal.pone.0174586 10.1007/s11136-005-3232-x
Prostate Cancer and Prostatic Diseases; Kaplan SA, Pichardo M et. al.
Apr 9th, 2021 - This is the first report of the 1-year outcomes of the EVEREST-I study evaluating the safety and efficacy of the Optilume® BPH Catheter System, a prostatic paclitaxel-coated balloon catheter system, for the treatment of lower urinary tract symptom...
https://doi.org/10.1038/s41443-021-00421-y 10.1007/s11255-015-1206-7 10.1016/j.eururo.2013.03.004 10.1016/j.juro.2011.01.074 10.1210/jc.2003-030330 10.3109/13685538.2016.1145205 10.1111/andr.12353 10.1111/jdv.14223 10.2340/00015555-3084 10.5534/wjmh.180082 10.1111/j.1743-6109.2012.02759.x 10.1016/j.euf.2019.05.014 10.1097/MD.0000000000017848 10.1111/j.1464-410X.2008.07498.x 10.1016/j.jep.2020.112779 10.1038/srep31906 10.1038/s41598-019-56145-z 10.1089/acm.2016.0302 10.1016/j.jep.2016.05.052 10.1080/01635581.2014.904911 10.1158/1940-6207.CAPR-14-0172 10.3390/ijms12063757 10.1016/j.fct.2012.08.004 10.1002/ptr.3001 10.1021/jf011102r 10.1021/jf800038h 10.1155/2014/640746 10.1677/joe.0.1810493 10.1038/sj.ijir.3901153 10.1177/1535370213508360 10.1016/j.phymed.2004.12.001 10.1016/S0022-5347(17)37500-6 10.1016/1043-6618(94)80012-X 10.1111/j.1743-6109.2011.02425.x 10.1111/j.1743-6109.2010.01992.x 10.1002/nau.24333 10.1161/ATVBAHA.110.209783 10.1073/pnas.1202916109 10.1007/BF01854965 10.3923/pjbs.2008.1569.1575 10.1016/j.ejphar.2016.08.006 10.1016/j.pain.2008.12.021 10.1016/j.jprot.2010.02.014 10.1016/j.eururo.2007.10.024 10.1016/j.niox.2015.08.005 10.1097/00005344-199904000-00001 10.1186/1743-7075-11-57 10.1097/01.hjh.0000198029.22472.d9 10.1016/j.biopha.2018.08.128 10.1186/s12933-016-0366-9 10.1111/jsm.12786 10.1021/jf0712503 10.1248/bpb.b17-00116 10.1016/S0302-2838(03)00198-2 10.1038/sj.bjc.6600825
International Journal of Impotence Research; Yilmaz-Oral D, Onder A et. al.
Apr 6th, 2021 - Benign prostatic hyperplasia (BPH) is one of the most prevalent conditions among aged men. The use of 5α-reductase inhibitors (5-ARIs) to treat BPH was linked to erectile dysfunction (ED). Many medicinal plants and secondary metabolites are used i...
https://doi.org/10.1080/13685538.2021.1901273
The Aging Male : the Official Journal of the Internationa... Wong A, Mahmalji W
Apr 5th, 2021 - Acute urinary retention (AUR) is one of the most significant complication of benign prostatic hyperplasia (BPH). The gold standard surgical treatment for BPH, transurethral resection of the prostate (TURP), is not without significant side effects ...
https://doi.org/10.1007/s00345-021-03685-7 10.1016/S0140-6736(03)13073-5 10.1016/j.juro.2008.03.141 10.1007/s00345-020-03219-7 10.1016/S0302-2838(03)00376-2 10.1016/j.eururo.2014.12.038 10.23736/S0393-2249.19.03589-6 10.1016/j.eururo.2017.07.005 10.1007/s00345-019-02852-1 10.1111/j.1464-410X.2010.09954.x 10.1016/j.urology.2006.08.1115 10.1038/sj.pcan.4500654 10.1016/j.eururo.2013.01.008 10.1111/bju.12982 10.1016/j.juro.2017.01.056 10.1016/j.juro.2015.10.181 10.1111/bju.14249 10.1038/nrurol.2015.169 10.1016/j.prnil.2017.01.007 10.1007/s00270-017-1662-9 10.1038/s41391-019-0196-4 10.1111/bju.14608 10.1111/bju.13358 10.1016/j.urology.2017.10.023 10.1016/j.eururo.2019.11.010 10.1111/bju.14917 10.1111/bju.14990 10.1016/j.juro.2013.12.004 10.1007/s00345-018-2509-y
World Journal of Urology; Frego N, Saita A et. al.
Apr 3rd, 2021 - To evaluate the feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation (TPLA) as a new minimally invasive surgical therapy (MIST) for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic h...
News 81 results
https://www.medscape.com/viewarticle/946349
Feb 24th, 2021 - NEW YORK (Reuters Health) - Photoselective vaporization of the prostate can provide relief from refractory lower-urinary-tract symptoms (LUTS) resulting from benign prostatic hyperplasia (BPH) in prostate cancer patients managed by active surveill...
https://www.medscape.com/viewarticle/945551
Feb 8th, 2021 - Certain drugs currently used to treat benign prostatic hyperplasia (BPH) may provide neuroprotection and delay or prevent the onset of Parkinson's disease, new research suggests. Treatment of BPH with terazosin (Hytrin), doxazosin (Cardura), or al...
https://reference.medscape.com/viewarticle/943651
Jan 11th, 2021 - Benign prostatic hyperplasia (BPH) is present in as many as 60% of men in their 60s and 90% of men older than 70 years. BPH describes nonmalignant prostate tissue growth and commonly causes lower urinary tract symptoms (LUTS). Not all men with BPH...
https://www.staging.medscape.com/viewarticle/941123
Nov 18th, 2020 - NEW YORK (Reuters Health) - Urethral-sparing robot-assisted simple prostatectomy (usRASP) preserves ejaculatory function while relieving lower-urinary-tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH), according to findings from...
https://www.medscape.com/viewarticle/941123
Nov 18th, 2020 - NEW YORK (Reuters Health) - Urethral-sparing robot-assisted simple prostatectomy (usRASP) preserves ejaculatory function while relieving lower-urinary-tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH), according to findings from...
